Home › Funds › T. Rowe Price Investment Management, Inc. › PCVX
T. Rowe Price Investment Management, Inc. position in PCVX
VAXCYTE INC · Health Care
T. Rowe Price Investment Management, Inc. reported holding 14,300,004 shares of PCVX (VAXCYTE INC) in its Q3 2026 13F filing — a position valued at US$813.7M, representing 0.57% of its reported portfolio and ranking #39 among its reported holdings. T. Rowe Price Investment Management, Inc. has disclosed PCVX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How T. Rowe Price Investment Management, Inc.'s PCVX position evolved
T. Rowe Price Investment Management, Inc. first disclosed a stake in PCVX in Q3 2023 at 1,204,628 shares (US$61.4M). The position peaked in Q3 2026 at 14,300,004 shares, worth US$813.7M. Across 13 filings, T. Rowe Price Investment Management, Inc. increased the stake 10 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 14,300,004 shares valued at US$813.7M — an increase of 2,092,554 shares quarter over quarter.. Notable position changes include a 185% increase in Q1 2024 (shares rose 11% over the following quarter), a 122% increase in Q2 2025 (shares rose 11% over the following quarter), a 39% increase in Q3 2025 (shares rose 28% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.20M | $61.41M | New |
| Q4 2023 | 1.25M | $78.25M | Add |
| Q1 2024 | 3.55M | $242.70M | Add |
| Q2 2024 | 4.02M | $303.75M | Add |
| Q3 2024 | 4.05M | $463.23M | Add |
| Q4 2024 | 2.86M | $234.18M | Reduce |
| Q1 2025 | 2.70M | $102.05M | Reduce |
| Q2 2025 | 6.00M | $195.10M | Add |
| Q3 2025 | 8.32M | $299.52M | Add |
| Q4 2025 | 11.30M | $521.21M | Add |
| Q1 2026 | 12.13M | $704.64M | Add |
| Q2 2026 | 12.21M | $709.62M | Add |
| Q3 2026 | 14.30M | $813.67M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PCVX and 13F data
PCVX (VAXCYTE INC) is a Health Care company. 31 other funds we track also report a position in PCVX — the largest reported positions include Jupiter Topco LLC (US$1.04B), Janus Henderson Group (US$1.02B), RA CAPITAL MANAGEMENT, L.P. (US$652.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PCVX
- Jupiter Topco LLC 17.97M sh · $1.04B · Q2 2026
- Janus Henderson Group 17.92M sh · $1.02B · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 11.47M sh · $652.90M · Q3 2026
- Deep Track Capital, LP 3.51M sh · $199.89M · Q3 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 3.28M sh · $186.60M · Q3 2026
- Kynam Capital Management, LP 2.61M sh · $148.39M · Q3 2026
- Bellevue Group AG 2.32M sh · $132.14M · Q3 2026
- Caligan Partners LP 2.19M sh · $124.53M · Q3 2026
- Paradigm Biocapital Advisors LP 2.14M sh · $121.93M · Q3 2026
- Maverick Capital 1.61M sh · $93.78M · Q2 2026
- Pivotal bioVenture Partners Investment Advisor LLC 1.43M sh · $81.11M · Q3 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.38M sh · $78.53M · Q3 2026
More on T. Rowe Price Investment Management, Inc.
FAQ
How long has T. Rowe Price Investment Management, Inc. held PCVX?
T. Rowe Price Investment Management, Inc. has disclosed PCVX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is T. Rowe Price Investment Management, Inc.'s current position in PCVX?
As of Q3 2026, T. Rowe Price Investment Management, Inc. holds 14.30M shares of PCVX (VAXCYTE INC), valued at $813.67M, representing 0.57% of its reported portfolio and ranking #39.
Has T. Rowe Price Investment Management, Inc. been buying or selling PCVX?
In the latest 13F filing (Q3 2026), T. Rowe Price Investment Management, Inc. increased its position in PCVX. The position peaked in Q3 2026 at 14.30M shares.
Which other funds hold PCVX?
Other major institutional holders of PCVX include Jupiter Topco LLC, Janus Henderson Group, RA CAPITAL MANAGEMENT, L.P., among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.